Helen Whitaker
Men’s Heart Disease Risk: Answering Common Questions Using Latest CDC and NIH Data
Heart disease stands as the leading cause of death for men in the United States. It accounts for approximately one in…
Read More →FDA Requires Updated Warnings on Cardiovascular Risks for Certain Prostate Cancer Treatments
FDA Updates Labeling for GnRH Agonists With New Warnings on Diabetes and Cardiovascular Risks
Read More →FDA Labels, NEJM Trial Data, and NIH Findings on Semaglutide and Tirzepatide
Primary regulatory and clinical trial sources indicate that GLP-1 receptor agonists such as semaglutide produce…
Read More →Multiple Trials Show Lean Mass Loss Alongside Fat Reduction in Obesity Treatments
Three trials published in The New England Journal of Medicine tracked body composition changes during treatment with…
Read More →Heart Disease in Men: Answering Common Questions from Latest CDC Reports
What do CDC and MMWR data reveal about cardiovascular risk factors in men?
Read More →What Registry Data Show About Emerging Digital Prevention Approaches for Men's Heart Health
NIH-Funded Research Examines Digital Tools for Cardiovascular Risk Monitoring in Men
Read More →USPSTF Prostate Cancer Screening Recommendations: Evidence-Based Questions and Official Answers
The U.S. Preventive Services Task Force set its current standards for PSA-based prostate cancer screening in a 2018…
Read More →Cardiovascular Risk in Men: Answering Common Questions Using Latest CDC and NIH Reports
CDC and NIH Data Show High Prevalence of Cardiovascular Risk Factors Among U.S. Men Aged 40-59
Read More →How the FDA Classifies and Reviews Digital Tools for Wellness Tracking
How the FDA Classifies and Reviews Digital Tools for Wellness Tracking
Read More →FDA Implements New Regulatory Framework for Lab-Developed Tests After Years of Debate
FDA Implements New Regulatory Framework for Lab-Developed Tests After Years of Debate
Read More →Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men
Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men
Read More →FDA Detects Undeclared Sildenafil and Tadalafil in OTC Male Sexual Enhancement Products
FDA Detects Undeclared Sildenafil and Tadalafil in OTC Male Sexual Enhancement Products
Read More →